vs

Side-by-side financial comparison of Citizens Community Bancorp Inc. (CZWI) and IRIDEX CORP (IRIX). Click either name above to swap in a different company.

Citizens Community Bancorp Inc. is the larger business by last-quarter revenue ($15.8M vs $14.7M, roughly 1.1× IRIDEX CORP). On growth, Citizens Community Bancorp Inc. posted the faster year-over-year revenue change (14.9% vs -69.7%). Over the past eight quarters, IRIDEX CORP's revenue compounded faster (11.9% CAGR vs 1.9%).

Glacier Bancorp, Inc. is a regional multi-bank holding company headquartered in Kalispell, Montana, United States. It is a successor corporation to the Delaware corporation originally incorporated in 1990. The company provides personal and commercial banking services from 221 locations in Montana, Idaho, Utah, Washington, Wyoming, Colorado, Arizona, and, Nevada.

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

CZWI vs IRIX — Head-to-Head

Bigger by revenue
CZWI
CZWI
1.1× larger
CZWI
$15.8M
$14.7M
IRIX
Growing faster (revenue YoY)
CZWI
CZWI
+84.6% gap
CZWI
14.9%
-69.7%
IRIX
Faster 2-yr revenue CAGR
IRIX
IRIX
Annualised
IRIX
11.9%
1.9%
CZWI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CZWI
CZWI
IRIX
IRIX
Revenue
$15.8M
$14.7M
Net Profit
$4.3M
Gross Margin
37.2%
Operating Margin
31.0%
Net Margin
27.1%
Revenue YoY
14.9%
-69.7%
Net Profit YoY
58.1%
EPS (diluted)
$0.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CZWI
CZWI
IRIX
IRIX
Q4 25
$15.8M
$14.7M
Q3 25
$16.2M
$12.5M
Q2 25
$16.1M
$13.6M
Q1 25
$14.2M
$11.9M
Q4 24
$13.7M
$12.7M
Q3 24
$14.2M
$11.6M
Q2 24
$13.5M
$12.6M
Q1 24
$15.2M
$11.8M
Net Profit
CZWI
CZWI
IRIX
IRIX
Q4 25
$4.3M
Q3 25
$3.7M
$-1.6M
Q2 25
$3.3M
$-994.0K
Q1 25
$3.2M
$-1.7M
Q4 24
$2.7M
$-834.0K
Q3 24
$3.3M
$-1.9M
Q2 24
$3.7M
$-2.7M
Q1 24
$4.1M
$-3.5M
Gross Margin
CZWI
CZWI
IRIX
IRIX
Q4 25
37.2%
Q3 25
32.1%
Q2 25
34.5%
Q1 25
42.5%
Q4 24
44.0%
Q3 24
37.3%
Q2 24
40.7%
Q1 24
37.9%
Operating Margin
CZWI
CZWI
IRIX
IRIX
Q4 25
31.0%
Q3 25
27.9%
-11.3%
Q2 25
25.1%
-6.9%
Q1 25
28.0%
-1.7%
Q4 24
24.5%
-3.9%
Q3 24
29.5%
-16.1%
Q2 24
35.0%
-20.9%
Q1 24
34.2%
-28.0%
Net Margin
CZWI
CZWI
IRIX
IRIX
Q4 25
27.1%
Q3 25
22.7%
-12.6%
Q2 25
20.3%
-7.3%
Q1 25
22.5%
-14.2%
Q4 24
19.7%
-6.6%
Q3 24
23.1%
-16.7%
Q2 24
27.2%
-21.2%
Q1 24
26.9%
-29.5%
EPS (diluted)
CZWI
CZWI
IRIX
IRIX
Q4 25
$0.44
Q3 25
$0.37
$-0.09
Q2 25
$0.33
$-0.06
Q1 25
$0.32
$-0.10
Q4 24
$0.28
$-0.05
Q3 24
$0.32
$-0.12
Q2 24
$0.35
$-0.16
Q1 24
$0.39
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CZWI
CZWI
IRIX
IRIX
Cash + ST InvestmentsLiquidity on hand
$118.9M
$6.0M
Total DebtLower is stronger
$51.8M
Stockholders' EquityBook value
$187.9M
Total Assets
$1.8B
$29.2M
Debt / EquityLower = less leverage
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CZWI
CZWI
IRIX
IRIX
Q4 25
$118.9M
$6.0M
Q3 25
$82.4M
$5.6M
Q2 25
$67.5M
$6.8M
Q1 25
$100.2M
$7.2M
Q4 24
$50.2M
$2.4M
Q3 24
$36.6M
$3.9M
Q2 24
$36.9M
$4.1M
Q1 24
$28.6M
$5.4M
Total Debt
CZWI
CZWI
IRIX
IRIX
Q4 25
$51.8M
Q3 25
Q2 25
Q1 25
Q4 24
$66.6M
$1.0M
Q3 24
$1.4M
Q2 24
Q1 24
Stockholders' Equity
CZWI
CZWI
IRIX
IRIX
Q4 25
$187.9M
Q3 25
$186.8M
$4.7M
Q2 25
$183.5M
$6.1M
Q1 25
$180.1M
$852.0K
Q4 24
$179.1M
$2.1M
Q3 24
$180.1M
$2.6M
Q2 24
$176.0M
$4.2M
Q1 24
$172.8M
$6.5M
Total Assets
CZWI
CZWI
IRIX
IRIX
Q4 25
$1.8B
$29.2M
Q3 25
$1.7B
$28.4M
Q2 25
$1.7B
$31.6M
Q1 25
$1.8B
$34.2M
Q4 24
$1.7B
$29.1M
Q3 24
$1.8B
$30.2M
Q2 24
$1.8B
$31.2M
Q1 24
$1.8B
$34.1M
Debt / Equity
CZWI
CZWI
IRIX
IRIX
Q4 25
0.28×
Q3 25
Q2 25
Q1 25
Q4 24
0.37×
0.48×
Q3 24
0.53×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CZWI
CZWI
IRIX
IRIX
Operating Cash FlowLast quarter
$11.7M
Free Cash FlowOCF − Capex
$10.4M
FCF MarginFCF / Revenue
65.9%
Capex IntensityCapex / Revenue
8.3%
Cash ConversionOCF / Net Profit
2.74×
TTM Free Cash FlowTrailing 4 quarters
$17.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CZWI
CZWI
IRIX
IRIX
Q4 25
$11.7M
Q3 25
$6.6M
$-1.2M
Q2 25
$-406.0K
$-397.0K
Q1 25
$1.6M
$-1.1M
Q4 24
$20.4M
$-1.2M
Q3 24
$3.5M
$-3.1M
Q2 24
$5.1M
$-1.3M
Q1 24
$9.1M
$-1.6M
Free Cash Flow
CZWI
CZWI
IRIX
IRIX
Q4 25
$10.4M
Q3 25
$6.2M
$-1.2M
Q2 25
$-632.0K
$-410.0K
Q1 25
$1.5M
$-1.2M
Q4 24
$19.5M
$-1.2M
Q3 24
$3.4M
$-3.1M
Q2 24
$4.8M
Q1 24
$8.9M
$-1.7M
FCF Margin
CZWI
CZWI
IRIX
IRIX
Q4 25
65.9%
Q3 25
38.4%
-9.4%
Q2 25
-3.9%
-3.0%
Q1 25
10.7%
-9.8%
Q4 24
142.2%
-9.8%
Q3 24
23.8%
-26.5%
Q2 24
35.7%
Q1 24
58.9%
-14.0%
Capex Intensity
CZWI
CZWI
IRIX
IRIX
Q4 25
8.3%
Q3 25
2.4%
0.1%
Q2 25
1.4%
0.1%
Q1 25
0.7%
0.1%
Q4 24
6.5%
0.1%
Q3 24
0.9%
0.0%
Q2 24
2.3%
0.0%
Q1 24
1.4%
0.0%
Cash Conversion
CZWI
CZWI
IRIX
IRIX
Q4 25
2.74×
Q3 25
1.80×
Q2 25
-0.12×
Q1 25
0.50×
Q4 24
7.55×
Q3 24
1.07×
Q2 24
1.39×
Q1 24
2.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons